Table 4.
Weekly Neurosurgical Outpatient Clinic Visits Stratified by Gubernatorial Executive Order, Neurosurgical Subspecialty, and Encounter Type
| Variable | Before COVID-19 | During COVID-19 | Test Statistic (H) | P Value |
|---|---|---|---|---|
| Study period (weeks) | 7 | 7 | NA | NA |
| Weekly clinic visits | 329 (326–374) | 174 (160–190) | 36.75 | <0.001∗ |
| Weekly telehealth encounters | 0 (0–0) | 151 (126–156) | 73.50 | <0.001∗ |
| Weekly in-person encounters | 329 (326–374) | 29 (26–39) | 36.75 | <0.001∗ |
| Weekly spine encounters | 191 (182–207) | 87 (78–100) | 36.75 | <0.001∗ |
| Weekly vascular encounters | 26 (22–28) | 11 (8–16) | 21.20 | <0.001∗ |
| Weekly functional encounters | 30 (26–30) | 13 (9–19) | 15.12 | 0.002∗ |
| Weekly tumor encounters | 32 (20–34) | 18 (16–24) | 1.37 | 0.265 |
| Weekly pituitary encounters | 1 (0–4) | 3 (1–3) | 0.00 | 0.950 |
| Weekly pediatric encounters | 57 (44–66) | 27 (21–32) | 36.75 | <0.001∗ |
Data presented as median (interquartile range).
COVID-19, coronavirus disease 2019; NA, not applicable.
∗
Statistically significant.